Laparoscopy Devices Market Size, Share & Trends Analysis Report By Product Type (Laparoscopes, Energy Devices, Insufflators, Robot-Assisted Surgery Systems, Suction or Irrigation Systems, Closure Devices, Hand Instruments, Access Devices, Accessories, Others), By Applications (General Surgery, Bariatric Surgery, Gynecological Surgery, Urological Surgery, Colorectal Surgery, Others), By End-User (Hospitals , Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Laparoscopy Devices Market Size

The Laparoscopy Devices Market Size was valued at USD 27.17 Billion in 2024. It is projected to reach from USD 29.07 Billion by 2025 to USD 49.95 Billion by 2033, growing at a CAGR of 7% during the forecast period (2025–2033).

A minimally invasive surgical method called laparoscopy aids in detecting several abdominal and pelvic problems, including cysts, adhesions, fibroids, and infections of the female reproductive system. Laparoscopy, also called “keyhole” surgery, is performed by creating a small incision. Laparoscopes are inserted through a small incision in the abdomen, which captures pictures of abdominal organs. This procedure also assists in performing a biopsy of tissues and surgeries, such as cholecystectomy (laparoscopic gallbladder surgery), appendectomies (removal of the appendix) and anti-reflux surgery, treatment for acid reflux, also known as GERD (gastroesophageal reflux disease).

Laparoscopy devices are highly utilized in various surgical procedures as such devices have brought precision to the performance of surgical operations. Using laparoscopy devices in surgical procedures ensure minimal bleeding and assists in maintaining hemostasis. Surgeons and clinicians favor laparoscopy equipment due to the high surgical precision these technologies provide.

Highlights

• Energy devices dominate the product type segment.
• General surgery dominates the application segment.
• The hospital dominates the end-user segment.
• North America is the highest shareholder in the global market

Laparoscopy Devices Market Growth Factors

Growth in preference for minimally invasive procedures

The preference for laparoscopy-based surgeries has grown significantly in recent years because of the rise in demand for minimally invasive procedures. Patients most commonly resist undergoing open surgical procedures, which increases the need for “keyhole” surgeries. Minimally invasive surgical procedures offer desired benefits to patients, such as speedy recovery, less invasion during surgeries, and reduced pain after operations. Patients opt for minimally invasive procedures over open surgeries, as the former leads to reduced hospitalization time. 

Furthermore, minimally invasive procedures are employed across medical settings such as hospitals and clinics. This is attributed to the cost-effective solutions offered by such surgeries and the high precision level. Minimally invasive procedures are widely accepted by patients across the globe as there is reduced post-operative trauma. In addition, these procedures offer similar therapeutic benefits as those open surgeries. Moreover, a rise in the use of laparoscopy devices in cosmetic procedures has been observed in the past few years. In addition, growth in demand for minimally invasive surgeries in developed economies such as U.S. and Canada contribute to the market growth. 

Rise in incidences of colorectal cancer

Effective treatment of colorectal cancer implies surgical resection and laparoscope devices are applied for the same at a large scale. Laparoscopic devices are utilized to achieve bowel resection with better aesthetic results. In addition, these devices assist in treating colorectal cancer through minimal invasion without compromising oncological safety. Thus, the rise in the prevalence of colorectal cancer drives this market. 

In addition, an increase in cases of colorectal cancer among young adults is witnessed in developed economies. According to the American Cancer Society, there will be 104,610 new cases of colon cancer and 43,340 new cases of rectal cancer in 2020. This rise in the cases of colorectal cancer has increased the demand for effective treatment. This entails the use of laparoscopes for various surgical resections.

Restraining Factor

High cost of laparoscopic devices and procedures

High costs associated with laparoscopic surgeries may restrain adopting laparoscopic devices in surgical procedures. The use of robotic technology during laparoscopy has grown over the past few years, which has increased the overall cost of these operations. For instance, the da Vinci system used in robot-assisted laparoscopy cost USD 3.0 million and an annual maintenance of USD 180,000 in 2016.

In addition, robotic systems are accessible to a limited number of surgical centers in specific regions. Furthermore, robotic surgical procedures have fixed costs, with prices ranging from USD 1 million to USD 2.5 million per unit. To suffice the cost of these systems, surgeons must perform 150 to 250 procedures. Such instances hinder the growth of this market. Further, the need for more access to robot-assisted laparoscopes in a few developing regions constrains the development of this market.

Market Opportunity

Growth in the adoption of robot-assisted laparoscopy devices

Robot-assisted laparoscope devices aid in overpowering the limitations of traditional laparoscopes. Developing these devices aims to help surgeons offer improved patient care. In addition, robot-assisted laparoscopy includes all benefits of minimally invasive procedures, such as less post-operative pain, smaller, shorter hospital stay, shorter recovery time, and faster return to work. The da Vinci robot has been approved by the U.S. Food and Drug Administrating (FDA) for procedures in gynecological surgery. Robot-assisted laparoscopes are gaining traction in radical prostatectomy, partial nephrectomy, and gynecology procedures. Minimizing the overall costs of robot-assisted laparoscopes along with the reduction in the cost of maintenance are projected to offer profitable opportunities in the coming years.

Regional Insights

North America: Dominant region with 5.5% market share

North America held the largest market share and is anticipated to exhibit a CAGR of 5.5% during the forecast period. North America is renowned for its healthcare facilities and medical services; thus, the adoption of technologically advanced laparoscopy devices in the region is faster. The adoption rate for this is on the rise, with the growth in advancements in technologies used in these devices, such as novel 3D and 4D cameras for visualization, miniaturization devices, and direct energy systems. In addition, the rise in cases of morbid obesity in North America is the major factor that drives the market growth. As the prevalence of morbid obesity among Americans has increased, there will undoubtedly be a greater demand for weight-loss surgeries in the area, which will spur the development of laparoscopy equipment. In addition, robotic technology in laparoscopy devices has provided higher accuracy, creating many opportunities for the North America laparoscopy devices market.

Europe : Fastest growing region with the highest CAGR

Europe is projected to exhibit a CAGR of 4.6% during the forecast period. Europe is globally prominent for its excellent medical services and healthcare facilities, with several medical device companies that are pioneers in laparoscopy and medical imaging. B. Braun Melsungen AG and Henke-Sass Wolf GmbH are a few companies that deal with laparoscopy devices in the region. Europe has introduced a reimbursement system called diagnosis-related group (DRG) based hospital payment. It provides some opportunities for hospitals to upgrade their equipment with cost-effectiveness and clinically efficient technologies. Despite the slow recovery from the European financial crisis, laparoscopy devices have continued to grow in the region. UK, France, and Germany are the major countries in the Europe laparoscopy devices market. The market for laparoscopy devices is developing in Germany, Austria, and Switzerland, owing to increased demand for innovative and cost-effective surgical solutions. 

Asia-Pacific stands in third place. The laparoscopy device market is growing substantially in Asia-Pacific owing to the high population base of India and China, demanding a greater number of laparoscopy-based surgeries. In addition, significant improvements in laparoscopic techniques and instruments propel the market growth. A few regional players in the Asia-Pacific laparoscopy market include AngioDynamics, Inc., Teleflex, Inc., and Lumenis, Inc. Japan is the leading country in the Asia-Pacific laparoscopy devices market, owing to the growth in demand for technologically advanced laparoscopic surgery and the need for bariatric surgery. Furthermore, the demand for laparoscopy devices and surgeries in emerging markets such as China, India, Indonesia, Korea, and other countries is on the rise, thus fueling the market growth. India is an emerging economy with beneficial investment potential due to its robust financial systems and open foreign direct investments (FDI) policy. These factors contribute to the growth of the laparoscopy market. 

The laparoscopy market in LAMEA is anticipated to grow at a low pace due to a need for more skilled and trained professionals. A lack of awareness about using laparoscopy devices has been observed in this region. However, regional market players have shown large-scale investments in producing laparoscopy devices. Most market players have focused on expanding their foothold in the LAMEA region by adopting strategies, such as product launches, on discovering untapped opportunities in this region. For instance, Coloplast Corporation launched an Elefant suction device/irrigation device, which offers comfort and effectiveness for surgeons performing laparoscopic procedures. LAMEA has witnessed a rapid increase in disposable incomes. Growth in insurance reimbursement in rural and urban areas provides access to minimally invasive surgical techniques. The Government also invests in the healthcare sector, allowing more significant funding for lower-tier and rural hospitals and more training opportunities for surgeons. Therefore, diagnostic and therapeutic laparoscopy services are necessary throughout this region. This increase in demand is anticipated to propel the growth of the LAMEA laparoscopy devices market gradually.

Segmental Analysis

By Product Type

The energy devices segment is responsible for the largest market share and is anticipated to grow at a CAGR of 5.7% throughout the forecast period. Most laparoscopic procedures use devices that apply energy for tissue cutting, coagulation, desiccation, or fulguration to destroy or manipulate tissue. Devices used to supplement energy devices include camera heads, transmitters, ligation devices, video converters, monitors, and camera heads. In contrast, other energy sources include electricity, ultrasound, laser, argon gas, microwaves, and radio. Energy devices are employed in laparoscopic surgeries owing to continuous technological advancements. The need to close wounds after performing laparoscopic surgeries has resulted in the development of new energy devices. This aids in improving efficiency and minimizing the variability of laparoscopic surgeries. Growth in demand for single incision and other laparoscopic surgeries boosts energy device requirements in the laparoscopy device market.

Laparoscope is a medical device used to execute nonsurgical procedures for examining the visceral organs of patients for diagnostic and therapeutic purposes. Laparoscope is an essential tool for diagnosing and detecting various diseases of internal organs. These are employed in multiple applications, such as medical imaging and surgical procedures. Laparoscopes enhance the visualization of surgeries and monitor body cavities and organs. Technological advancements in laparoscopes and ancillary instruments in laparoscopic procedures boost market growth. Furthermore, laparoscopes reduce post-operative complications, are cost-effective surgical solutions, and reduce surgery-related infections, driving market growth.

By Applications 

The general surgery segment owns the highest market share and is expected to exhibit a CAGR of 4.7% during the forecast period. Due to the rise in cases of gall bladder removals, hernia patients, and appendix removal surgeries, general surgery significantly impacts the growth of the laparoscopic device market. General surgery is further segmented into cholecystectomies, hernia repairs, appendectomies, and anti-reflux surgeries. Laparoscopic cholecystectomies dominate the general surgery segment, whereas laparoscopic hernia repair is anticipated to proliferate during the forecast period.

Bariatric surgeries comprise various procedures performed on people suffering from obesity. These surgeries assist in weight loss by reducing the stomach size with the help of a gastric band. Laparoscopic bariatric surgeries include the removal of a portion of the stomach (sleeve gastrectomy) and resecting of the small intestine to a small pouch (gastric bypass surgery). Due to their promise to treat diabetes and problems linked to cardiovascular diseases, laparoscopic-based bariatric surgical treatments have gained popularity. Laparoscopic bariatric surgery also helps to treat conditions linked to obesity, including type 2 diabetes, high blood pressure, dangerous cholesterol levels, and sleep apnea.

By End-User

The hospital segment dominates the market and is estimated to exhibit a CAGR of 5.3% during the forecast period. Hospitals hold the most significant market share in the worldwide market laparoscopy devices due to the growing use of laparoscopy equipment in operating rooms. Hospitals prefer laparoscopic surgeries over open surgeries owing to their reduced costs and high precision. In addition, the average length of hospital stays has also decreased, along with increased patient satisfaction. This is the primary factor contributing to the growth in hospital demand for it. Furthermore, initiatives encouraging the adoption of minimally invasive techniques in developing regions have supplemented the increase in demand for hospital laparoscopy devices. 

Clinics are modern healthcare facilities that focus on providing same-day surgical care, including diagnostics and preventive procedures. Clinics are the fastest-growing segment of this market and are anticipated to maintain a lucrative growth rate during the forecast period. Clinics generally have different laparoscopy devices to visualize and detect different diseased states. Clinics carry out biopsies of tissue samples to detect cancer and other diseases, which require incorporating it. They enable a safe, cost-effective, and patient-friendly environment for all age groups to endow medical services such as appendectomy, gastrectomy, and cholecystectomy. 

Recent Developments

• March 2023- Ronovo Surgical recently invited prominent gynecological and urology surgeons to assess the performance of its recently announced CarinaTM RAS Platform, the first Chinese robotic-assisted surgery (RAS) platform built for laparoscopic procedures.
• February 2023- TELA Bio announced the U.S. commercial launch of two novel OviTex® LPR device configurations for robotic and laparoscopic repair of massive abdominal hernias.